Saturday, 29 January 2022

Tag Archives: Pfizer

EU Signs Contract with Pfizer for 1.8B Vaccine

FILE – Health workers prepare doses of the Pfizer-BioNTech COVID-19 vaccine at a vaccination center in Naples, Italy, Jan. 8, 2021. Photo – Reuters LONDON – The European Union Thursday announced it has signed a third contract with Pfizer-BioNTech for an additional 1.8 billion doses of its COVID-19 vaccine, running ...

Read More »

96% develop antibodies a month after single jab

wildpixel; iStock by Getty Images LONDON – More than nine in 10 people given the Pfizer or AstraZeneca Covid-19 vaccine develops antibodies after a single dose, a new London based study suggests. And nearly every single person develops an antibody response after the second jab, the study implies. Antibodies help ...

Read More »

Pfizer, BioNTech launch vaccine trial in kids under 12

NEW YORK – Pfizer Inc and German partner BioNTech SE began testing their Covid-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the US drugmaker said on Thursday. The first volunteers in the early-stage trial were given their first injections on ...

Read More »

UK to introduce covid-19 vaccine next week

LONDON: Britain on Wednesday became the first Western country to approve a Covid-19 vaccine for general use, announcing a rollout of Pfizer-BioNTech’s drug from next week in a historic advance for humanity’s fightback against the coronavirus. “Help is on its way,” health secretary Matt Hancock tweeted as his department announced ...

Read More »

UK, Germany Start Trials of COVID-19 Vaccine

BERLIN: The race to develop an effective vaccine against the novel coronavirus gathered pace this week, as clinical trials on humans were approved in Germany and launched in the UK. Though there are now around 150 development projects worldwide, the German and British plans are among only five clinical trials ...

Read More »

Pfizer in talks to merge off-patent drugs business

NEW YORK: Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, according to a source familiar with the matter. Mylan shareholders would receive a little more than 40% of the newly formed entity, with Pfizer shareholders receiving the remainder, the person ...

Read More »

Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance

Pfizer has agreed to pay German biotech firm BioNTech up to $425 million (£334.33 million) in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach. Privately-held BioNTech will receive $120 million upfront plus up to $305 ...

Read More »